SARS-CoV-2 Proficiency Testing Scheme
EPTIS Ringversuch Nr. 769005 | Letze Änderung 2022-05-04 | URL: https://www.eptis.bam.de/pts769005 https://www.eptis.bam.de/pts769005
Name des Anbieters | |||||||||||||||||||||||||||||||
Name des Anbieters | LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing | ||||||||||||||||||||||||||||||
Ansässig in | United Kingdom | ||||||||||||||||||||||||||||||
Sprache(n) | |||||||||||||||||||||||||||||||
Anmerkungen | The primary aim of the Clinical Laboratory proficiency testing scheme (CLS) is to enable laboratories performing analysis of clinical samples to monitor their performance and compare it with that of their peers. The CLS scheme also aims to provide information to participants on technical issues and methodologies relating to Clinical Laboratory Science. The CLS scheme year operates from January to December. Further information about CLS, including test material availability, round despatch dates and reporting deadlines, are available on the current CLS application form. The operation of the scheme is supported by an Advisory Group consisting of experts in the field of Clinical Laboratory Science and proficiency testing. The scheme reports on the performance of U.K. participants to the National Quality Assurance Advisory Panels for Chemical Pathology and for Medical Microbiology. | ||||||||||||||||||||||||||||||
Klassifizierung | |||||||||||||||||||||||||||||||
Produktgruppen |
Human test material
|
||||||||||||||||||||||||||||||
Prüfgebiete |
Biology
Medical analysis Microbiology |
||||||||||||||||||||||||||||||
Technische Einzelheiten | |||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
Ringversuchsziele | |||||||||||||||||||||||||||||||
Zielgruppe des Ringversuchs | Clinical laboratories, other | ||||||||||||||||||||||||||||||
Relevante Rechtsvorschriften oder Normen | |||||||||||||||||||||||||||||||
Weitere Ziele | validation of testing methods | ||||||||||||||||||||||||||||||
Teilnehmerzahl | |||||||||||||||||||||||||||||||
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch A2LA, UKAS, ILAV-MRA auf der Grundlage von ISO/IEC 17043:2010 nicht für alle Parameter |
||||||||||||||||||||||||||||||
Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||||||||||||||||||||||||||
Kosten | |||||||||||||||||||||||||||||||
Teilnahmegebühr | Fees vary according to selection from available groups. | ||||||||||||||||||||||||||||||
Regelmässig durchgeführt | Ja (12 rounds per year) | ||||||||||||||||||||||||||||||
Der Ringversuch wird durchgeführt seit | 2018 | ||||||||||||||||||||||||||||||
Kontaktdaten des Anbieters | |||||||||||||||||||||||||||||||
Anbieter | Kontaktperson | ||||||||||||||||||||||||||||||
LGC AXIO Proficiency Testing
1 Chamberhall Business Park, Chamberhall Green BL9 0AP Bury, Greater Manchester United Kingdom Telefon: +44 (0)161 762 2500 Fax: +44 (0)161 762 2501 Web: https://www.lgcstandards.com/GB/en/Proficiency-Testing/cat/244597 https://www.lgcstandards.com/GB/en/Proficiency-Testing/cat/244597 |
Mrs Nicola Armstrong
Telefon: +44 (0)161 762 2500 Fax: E-Mail: axiopt@lgcgroup.com axiopt@lgcgroup.com |